| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
DNA polymerase epsilon 4, accessory subunit | 0.653 | 0.538 | 7.0E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
RAD18 E3 ubiquitin protein ligase | 0.691 | 0.346 | 1.6E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
proteasome 20S subunit beta 9 | 0.514 | 0.808 | 2.7E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
rhodopsin | 0.525 | 0.769 | 1.3E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
superoxide dismutase 3 | 0.531 | 0.808 | 7.2E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
tyrosine aminotransferase | 0.492 | 0.846 | 6.9E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily C member 1 | 0.566 | 0.769 | 1.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
alpha and gamma adaptin binding protein | 0.695 | 0.538 | 3.9E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
Myeloid leukemia-related gene (myeloid tumor suppressor) | 0.564 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | |||||||||
|
caspase 10 | 0.528 | 0.692 | 4.6E-12 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
microtubule associated protein 1 light chain 3 alpha | 0.610 | 0.654 | 2.8E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
TOX high mobility group box family member 2 | 0.736 | 0.154 | 3.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
caveolin 2 | 0.575 | 0.692 | 2.7E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 15 | 0.626 | 0.577 | 2.4E-16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
microtubule associated protein 1 light chain 3 beta | 0.506 | 0.846 | 1.9E-03 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2017 | 2019 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2019 | ||||||||
|
optineurin | 0.548 | 0.808 | 5.9E-18 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2020 | ||||||||
|
CCAAT enhancer binding protein beta | 0.508 | 0.731 | 0.36 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2015 | ||||||||
|
vasohibin 1 | 0.601 | 0.423 | 0.33 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2018 | 2019 | ||||||||
|
PH domain and leucine rich repeat protein phosphatase 2 | 0.641 | 0.346 | 1.2E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2019 | ||||||||
|
KN motif and ankyrin repeat domains 1 | 0.641 | 0.538 | 8.0E-18 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2018 |